Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-31 @ 1:30 PM
Study NCT ID:
NCT06727604
Status:
RECRUITING
Last Update Posted:
2025-12-08
First Post:
2024-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Sponsor:
Immunovant Sciences GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-09
First Submit QC Date:
None
Study First Post Date:
2024-12-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED